Ep34: Investing in Digital Health: Justin Norden Shares Insights Into Succeeding in DTx
In this episode, we take a break from interviewing entrepreneurs and switch gears to get into a head of one of the investors in the industry, Justin Norden.
Justin is a Partner at GSR Ventures where he focuses on early-stage investments in digital health. Prior to GSR Ventures, he was CEO and co-founder of Trustworthy AI which was acquired by Waymo (Google self-driving). He worked on the healthcare team at Apple, co-founded Indicator (an NLP based platform for biopharma decision making), and helped start the Stanford Center for Digital Health.
In this episode, we cover:
The Healthcare Thesis at GSR Ventures
Virtual Reality (VR) Digital Therapeutics
Stand-alone DTx (biotech-like pipelines) vs. Drug+ DTx
What it would take to scale existing Prescription Digital Therapeutics
The Role Of Health Coaching alongside AI automation
The Drivers of Success Going Forward for the Digital Therapeutics Market
Guest Links and Resources:
Connect with Justin Norden on LinkedIn | Twitter
Visit https://gsrventuresglobal.com
Host Links:
Connect with Eugene Borukhovich: Twitter | LinkedIn
Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn
Connect with YourCoach.health: Website | Twitter
Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App
HealthXL: Website | Twitter | Join an Event
Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:
> Presenting Partner: Amalgam Rx
> Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health
Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram
Ep34: Investing in Digital Health: Justin Norden Shares Insights Into Succeeding in DTx